Managing Privacy: The Imperative RWE Capability
Take the lead in Real-World Evidence Privacy Management
Leveraging real-world evidence (RWE) solutions are essential to driving new insights in healthcare. RWE success requires granular patient-level data. Balancing use while maintaining strict compliance with privacy and regulatory standards is a serious challenge for healthcare organizations looking to develop RWE capabilities. As privacy compliance standards are changing frequently, healthcare organizations need to be confident in their privacy practices when leveraging PHI for secondary uses.
This new QuintilesIMS/Privacy Analytics white paper on managing privacy for real-world evidence can keep you current and help build an effective privacy governance framework while achieving more useful, faster insights. Written by Dr Ben Hughes and Dr Khaled El Emam, this white paper addresses:
- Use risk-based versus masking approaches to gain higher-quality research data
- Use and link multiple data types, large scale databases and prospective cohorts
- Work effectively with health systems to share data and improve patient outcomes
- Implement at scale through software automation
Download your copy of Managing Privacy: The imperative RWE capability by filling in the form on the right.
You might also like:
Richer real-world insights. Stronger patient privacy.
While privacy is the responsibility of all healthcare organizations, life-science companies and real-world evidence (RWE) leaders are driving and benefiting…
RWE and Risk: A Primer
Balancing the Demand for Deep Data with Patient Privacy As pharma companies have become more sophisticated in their use of…
Building a De-identification Pipeline to Support RWE
To use patient-level data for RWE initiatives, biopharmaceutical companies must first obtain the patient’s consent that their data can be…
Experiences Building a RWE Database
Privacy Analytics’ de-identified EMR data so that it could be safely utilized without putting patient privacy at risk. IMS Brogan…